| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 04/06/2010 | US7691879 Isoquinoline potassium channel inhibitors |
| 04/06/2010 | US7691834 Substance for lowering high cholesterol level in serum and methods for preparing and using the same |
| 04/06/2010 | US7691603 Intracellular formation of peptide conjugates |
| 04/06/2010 | US7691566 Compositions and methods for treatment of cancer |
| 04/06/2010 | US7691378 Treating carcinomas or adenocarcinomas using at least one anti-TNF (tumor necrosis factor) antibody |
| 04/06/2010 | CA2453383C Piperidine derivatives as nmda receptor antagonists |
| 04/06/2010 | CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/06/2010 | CA2351709C Novel triazolo(4,5-d)pyrimidine compounds |
| 04/01/2010 | US20100081782 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 04/01/2010 | US20100081634 Novel Phosphorus-Containing Thyromimetics |
| 04/01/2010 | US20100081192 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
| 03/31/2010 | EP2168946A1 Crystalline form of modafinil, and methods of preparing the crystalline form |
| 03/31/2010 | EP2168598A1 Method of Treatment Using Ligand-Immunogen Conjugates |
| 03/30/2010 | US7687625 Antidiabetic agents; obesity; controlling appetite |
| 03/30/2010 | US7687506 Selective serine/threonine kinase inhibitors |
| 03/30/2010 | US7687498 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases |
| 03/30/2010 | US7687476 administering 4-thiouridine, isomaltitol and uridine as antiinflammatory agents and/or problems in hemostasis related to platelet function |
| 03/30/2010 | US7687065 Gel composition for skin care and protection and a method for preparation thereof |
| 03/30/2010 | CA2374755C Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 03/25/2010 | US20100076175 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs |
| 03/25/2010 | US20100076073 Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders |
| 03/24/2010 | EP1636231B1 Methods for preparing 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine using a compound of 2-amino-9-(2-substituted ethyl)purines |
| 03/24/2010 | EP1620060B1 Methods and devices for the sustained release of multiple drugs |
| 03/24/2010 | EP1615699B1 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 03/24/2010 | CN101675992A Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/24/2010 | CN100594919C Compositions containing an active fraction isolated from lycium barbarum and methods of using the same |
| 03/23/2010 | US7683067 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3) |
| 03/23/2010 | US7683059 Triazole compounds and uses related thereto |
| 03/23/2010 | US7683036 especially nucleic acid and nucleic acid-like oligomers, which are targeted to or mimic nucleic acids comprising or encoding small non-coding RNAs, and which act to modulate the levels of small non-coding RNAs, or interfere with their function |
| 03/23/2010 | US7682631 Adhesin-specific nanoparticles and process for using same |
| 03/23/2010 | US7682623 Pharmaceutical composition for topical application |
| 03/23/2010 | CA2380951C Pharmaceutical compositions for oral and topical administration |
| 03/23/2010 | CA2378052C Use of ginkgo extract |
| 03/23/2010 | CA2311755C Therapeutic formulation for administering tolterodine with controlled release |
| 03/18/2010 | US20100069408 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 03/17/2010 | EP2163643A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/17/2010 | EP2163546A1 Quinazoline derivatives |
| 03/17/2010 | EP1641423B1 Benzodiazepine cgrp receptor antagonists |
| 03/17/2010 | EP1620411B1 Inhibitors of akt activity |
| 03/17/2010 | CN101670105A Humanized antibodies chelated with amylord beta peptide |
| 03/17/2010 | CN101669900A Polymeric delivery formulations of leuprolide with improved efficacy |
| 03/16/2010 | US7678774 Treating severe acute respiratory syndrome |
| 03/16/2010 | US7678395 stimulating the growth of hair in an area on the surface of a hair-bearing subject by administering to said area a composition that comprises isolated and purified isoginkgetin |
| 03/11/2010 | US20100062972 Triazole compounds and uses related thereto |
| 03/11/2010 | US20100062971 such as 2-{3-[2-(4-Methoxy-phenyl)-ethyl]-6-methyl-1H-indazol-4-yloxy} beta -D-glucopyranoside, used for for treating diabetes, Syndrome X, obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, polycystic ovarian syndrome, hypertension, ischemia, stroke and cardiovascula disorders |
| 03/11/2010 | US20100062018 Mycoplasma hyopneumoniae bacterin vaccine |
| 03/10/2010 | EP2161268A1 Carbacephem beta-lactam compounds for the treatment of bacterial infections |
| 03/10/2010 | EP2161258A2 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 03/10/2010 | EP2161037A2 Camptothecin-Somatostatin conjugates |
| 03/10/2010 | EP1651628B1 Antibiotic compound |
| 03/09/2010 | US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment |
| 03/09/2010 | US7674769 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI) |
| 03/09/2010 | US7674470 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis |
| 03/09/2010 | US7674460 Compositions and methods for restoring sensitivity to treatment with HER2 antagonists |
| 03/04/2010 | US20100056551 Anti-cancer cyclopenta [G] quinazoline compounds |
| 03/04/2010 | US20100055150 Method and composition for treatment of skeletal dysplasias |
| 03/04/2010 | US20100055122 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 03/04/2010 | US20100055086 Antimicrobial Flush Solutions |
| 03/03/2010 | EP2159230A1 Anti-TNF antibodies, compositions, methods and uses |
| 03/03/2010 | EP2158900A1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 03/03/2010 | EP1675465B1 Improved combination bacteriolytic therapy for the treatment of tumors |
| 03/03/2010 | EP1613274B1 Human il-18 substitution mutants and their conjugates |
| 03/03/2010 | EP1162998B1 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 03/03/2010 | CN101658673A Method of treating diabetes |
| 03/02/2010 | US7671092 Paclitaxel enhancer compounds |
| 03/02/2010 | US7671085 Non-steroidal farnesoid X receptor modulators and methods for the use thereof |
| 03/02/2010 | US7671053 such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide for treatment of asthma and COPD; purinergic receptors (P2X7) |
| 03/02/2010 | US7671026 administering to an interstitial cystitis-afflicted subject a pharmaceutically effective amount of a composition comprising an oligopeptide comprising the disclosed amino acid sequence |
| 03/02/2010 | US7671022 administering molecules that block endogenous costimulatory (B7) interactions with cytotoxic t lymphocytes(CTLA4) and/or CD28 antigens |
| 03/02/2010 | US7671011 peptide comprises at least two positively charged amino acid residues; the peptide after conjugation to the fatty acid possessing antibacterial, antifungal, and/or anticancer activity higher than prior to conjugation; suitable for treatment of infections caused by pathogenic organisms such as bacteria |
| 03/02/2010 | CA2519117C High potency dopaminergic treatment of neurological impairment associated with brain injury |
| 02/25/2010 | WO2004092124A8 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 02/24/2010 | EP2156845A1 Combined vaccines comprising hepatitis B surface antigen and other antigens |
| 02/24/2010 | EP1620061B1 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 02/24/2010 | EP1615615B1 Tamper-resistant products for opioid delivery |
| 02/24/2010 | CN101654470A Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 02/24/2010 | CN101654437A Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds |
| 02/24/2010 | CN101653594A Somatostatin-dopamine chimeric analogs |
| 02/24/2010 | CN100591686C CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 02/24/2010 | CN100591657C Indane acetic acid compound |
| 02/24/2010 | CN100591336C Extract of trapa natans and methods of using the same |
| 02/23/2010 | US7666895 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation |
| 02/23/2010 | US7666881 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha -dimethylbenzene acetic acid hydrochloride formed by azeotropic distillation |
| 02/23/2010 | US7666862 2,4-Diphenyl-1-(hexamethylenimin-4-ylaminocarbonyl)dihydropyrrole derivatives that are useful for treating cancer |
| 02/23/2010 | US7666857 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3′-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
| 02/23/2010 | US7666439 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 02/23/2010 | US7666434 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 02/23/2010 | CA2378945C Multi-dose erythropoietin formulations |
| 02/23/2010 | CA2344173C Immunogenic liposome compositions |
| 02/18/2010 | WO2004084705A9 Quantitative detection of h. pylori in biological samples |
| 02/18/2010 | US20100041867 Reversible pegylated drugs |
| 02/17/2010 | EP2153849A2 Contraception process and administration form for the same |
| 02/17/2010 | EP2153825A1 Therapeutic formulation for administering tolterodine with controlled release |
| 02/17/2010 | EP1581123B1 Antimicrobial suture coating |
| 02/17/2010 | CN100589839C Polypeptide and medicament composition containing polypeptide |
| 02/17/2010 | CN100589797C Extended release venlafaxine formulation |
| 02/16/2010 | US7662846 Selective spirocyclic glucocorticoid receptor modulators |
| 02/16/2010 | US7662835 Methods of treating allergic reactions using an anhydrous form of antihistaminic piperidine derivatives |
| 02/16/2010 | US7662780 Administering hypocretin to obese individuals |
| 02/16/2010 | US7662607 Chalaropsis lysozyme protein and its method of use in anti-bacterial applications |